Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19, the company said. The new initiative of Novartis…
Read More
New drug to rescue leishmaniasis patients in Africa
Leishmaniasis patients in Eastern Africa may soon benefit from a new drug set to be developed by collaboration of Novartis,…
Read More
Treatment-resistant malaria: Are we winning the battle?
By Nathan Mulure – The history of resistance to antimalarials in Africa is not a happy one. At one time…
Read More
Novartis to introduce affordable chronicle diseases’ treatment to Ethiopia
By Andualem Sisay Gessesse – Novartis, a global healthcare company based in Switzerland, is set to introduce a new program…
Read More
Cooperation key in the face of globalization backlash
The international political climate may be turning against globalization and threatening economic growth, but there is still a chance to…
Read More
